Pharmacokinetic (PK) interactions between capecitabine (X), oxaliplatin (O) and bevacizumab (A) when used in combination for first-line treatment of metastatic colorectal cancer (MCRC)Barbara J. Brennan, S Choudhury, Bindi Dhesy-Thind et al.|Journal of Clinical Oncology|2007Cited by 5